In the present study, we compared the expression level of Rab32 between normal brain tissues and different subgroups of gliomas based on both cancer public datasets and clinical tissue samples, and found elevated Rab32 expression in GBMs, especially in the most malignant mesenchymal subtype. Here, RAB32 is linked to cancer.